Comparative In Vitro Evaluation Of Different Brands Of Metformin Hydrochloride Film Coated Tablets Marketed In Addis Ababa, Ethiopia
Metformin hydrochloride is a biguanide class of drug widely used to treat Type 2 diabetes mellitus. Its oral bioavailability is about 50 to 60 % with a half-life of about 3 h. This study focused on evaluation and comparison of the physicochemical properties of different brands of metformin hydrochloride (500mg) film coated tablets available in drug retail outlets in Addis Ababa, Ethiopia. Some different in vitro tests including hardness, weight variation, disintegration time, dissolution study, and assay were conducted as per United States Pharmacopeia. To compare dissolution profiles of the generic products against the innovator product (product A), a model independent method, similarity factor (f2), was also used. Weight variation result showed that all brand fall within the 5% limit from the average which is acceptable. Disintegration time of less than 15 minutes was observed for all brands. The in vitro drug release study results for the products ranged between 82 and 93% release within 30 minutes which is above 80% limit as per the United States Pharmacopeia requirement. The similarity f2 values for generic products ranged from 53 to 75%. Furthermore, assay value of the studied brands varied from 95.60 to 104.37% which was within standard limit (95-105%). It can be concluded that all brands of metformin hydrochloride tablets met pharmacopoeial specification for the tested parameters of physicochemical properties like weight variation, hardness of tablets, disintegration time, drug release study and assay.
2. Prithi IJ, Chowdhury SF, Chowdhury ST. Comparative in vitro dissolution test and other physicochemical parameters of some commercially available metformin HCl brands in Bangladesh. Pharma Innov. 2018; 7:5-8.
3. Ramalingam P, Reddy YP, Kumar KV, Chandu BR, Rajendran K. Evaluation of metformin hydrochloride in Wistar rats by FTIR‑ATR spectroscopy: A convenient tool in the clinical study of diabetes. J Nat Sc Biol Med. 2014; 5:288-292.
4. Sachan AK, Kumar V, Gupta A. Comparative in-vitro evaluation of four different brands of metformin HCl available in Kanpur district, India. Pharm Lett. 2016; 8:419-424.
5. Garza-Ocanas L, Gonzalez-Canudas J, Tamez-dela OE, Badillo-Castan C, Gomez-Meza MV, Romero-Antonio Y, Molina-Perez A, Amador-Hernandez AG. Comparative Bioavailability of Metformin Hydrochloride Oral Solution Versus Metformin Hydrochloride Tablets in Fasting Mexican Healthy Volunteers. Adv Ther. 2018; 36:407-415.
6. Mokhtare B, Cetin M, Ozakar RS, Bayrakceken H. In vitro and in vivo evaluation of alginate and alginate-chitosan beads containing metformin hydrochloride. Trop J Pharm Res. 2017; 16:287-296.
7. World Health Organization. Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms. Technical Report Series, No 937, 2006, Annex 8.
8. Osman Z, Osman AE, Abedelghayoum AM. Comparative evaluation of physicochemical properties of some commercially available brands of metformin HCl tablets marketed in Sudan. IAJPR. 2017;7:7471-7477.
9. Hanafy AF. In-vitro bioequivalence, physicochemical and economic benefits study for marketed innovator and generic ciprofloxacin hydrochloride tablets in Saudi Arabia. J Appl Pharm Sci. 2016;6:63-68.
10. Tacca MD, Pasqualetti G, Paolo AD, Virdis A, Massimetti G, Gori G, Versari D, Taddei S, Blandizzi C. Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Br J Clin Pharmacol. 2009; 68:34-42.
11. Alghannam AFA, Aslanpour Z, Evans S, Schifano S. A systematic review of counterfeit and substandard medicines in field quality surveys. Integr Pharm Res Pract. 2014; 3:71-88.
12. Adegbolagun OA, Olalade OA, Osumah SE. Comparative evaluation of the biopharmaceutical and chemical equivalence of some commercially available brands of ciprofloxacin hydrochloride tablets. Trop J Pharm Res. 2007; 6:737-745.
13. Eraga SO, Arhewoh MI, Oruh EP, Iwuagwu MA. A comparative evaluation of the pharmaceutical quality of different brands of metformin hydrochloride tablets available in Abuja, Nigeria. WAJP. 2017; 28:61-71.
14. Afifi SA and Ahmadeen S. A Comparative Study for Evaluation of Different Brands of Metformin Hydrochloride 500 Mg Tablets Marketed in Saudi Arabia. Life Sci J. 2012; 9:4260-4266.
15. Olusola AM, Adekoya AI, Olanrewaju OJ. Comparative Evaluation of Physicochemical Properties of Some Commercially Available Brands of Metformin HCl Tablets in Lagos, Nigeria. J Appl Pharm Sci. 2012; 2:41-44.
16. Sougi A, Ofori-Kwakye K, Kuntworbe N, Kipo SL, Boakye-Gyas ME. Evaluation of the Physicochemical and in vitro Dissolution Properties of Metformin Hydrochloride Tablet Brands Marketed in Five Cities in Ghana. Br J Pharm Res. 2016; 9:1-14.
17. Zakeri-Milani P, Nayyeri-Maleki P, Ghanbarzadeh S, Nemati M, Valizadeh H. In-vitro bioequivalence study of 8 brands of metformin tablets in Iran market. J Appl Pharm Sci. 2012; 2:194-197.
18. World Health Organization. Global surveillance and monitoring system for substandard and falsified medical products [internet]. [Cited 2019 November 21]. Available from: https://www.who.int › medicines › regulation › ssffc › surveillance.
19. Krishnaiah YSR, Yang Y, Bykadi S, Sayeed VA, Khan MA. Comparative evaluation of in vitro efficacy of colesevelam hydrochloride tablets. Drug Dev Ind Pharm. 2014; 40:1173-1179.
20. Wong SS, Ngo SNT. Use of In vitro Dissolution Testing to Assess Multiple Generic Metformin Tablets. J Pharm Res Int. 2018; 21:1-9.
21. United States Pharmacopoeia/National Formulary (USP36/NF31). The United States Pharmacopoeial Convention. Rockville, MD, USA; 2013.
22. Getachew A, Desta W, Bekele A. Comparison of Enset Starch with Other Widely Known Commercial Starches and Its Significant Applications in Pharmaceuticals. Br Biotechnol J. 2016; 14:1-8.
23. Hettiarachchi TW, Wickramaratne DBM, Sudeshika SHT, Niyangoda D, Sakeena MHF, Herath HMDR. Comparative in-vitro evaluation of metformin HCl and paracetamol tablets commercially available in Kandy district, Sri Lanka. Int J Pharm Pharm Sci. 2015; 7:520-524.
24. Gupta MM, Gupta M. In-vitro Pharmaceutical Quality Control Testing: a Comparative study of Different Brands of Metformin Tablets Available in the Trinidad & Tobago, West Indies. J. Pharm. Sci. & Res. 2016; 8:238-243.
25. Guidelines for Bioavailability & Bioequivalence Studies, Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, New Delhi [internet]. [Cited 2019 November 15]. Available from: https://cdscoonline.gov.in › CDSCO.
26. Guidance for Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms [internet]. [Cited 2019 November 16]. Available from: https://www.fda.gov › media › download.
27. Thakuri GMS, Yadav KK, Chhetri RR. Comparative in-vitro analysis of different brands of paracetamol tablets available in Nepal. JCLM. 2016; 4:645-648.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).